234 related articles for article (PubMed ID: 31008801)
21. Real-world experience with weight gain among pregnant women living with HIV who are using integrase inhibitors.
Fuller T; Fragoso da Silveira Gouvêa MI; Benamor Teixeira ML; Ferreira Medeiros A; Amorim da Silva P; Medeiros Braga C; Constan Werneck Sant'anna M; de Mattos Salgueiro M; da Silveira Bressan C; Mendes-Silva W; João EC
HIV Med; 2023 Mar; 24(3):301-310. PubMed ID: 36065478
[TBL] [Abstract][Full Text] [Related]
22. Integrase Inhibitors: After 10 Years of Experience, Is the Best Yet to Come?
Brooks KM; Sherman EM; Egelund EF; Brotherton A; Durham S; Badowski ME; Cluck DB
Pharmacotherapy; 2019 May; 39(5):576-598. PubMed ID: 30860610
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness of integrase strand transfer inhibitors among treatment-naive people living with HIV/AIDS in Guangdong, China: A real-world, retrospective cohort study.
Chen M; Liu C; Xie J; Tang X; Zhang Y; Pan D; Zhong H; Du P; Li Q; Li L; Gu J; Cai W
Medicine (Baltimore); 2024 Jun; 103(23):e38497. PubMed ID: 38847660
[TBL] [Abstract][Full Text] [Related]
24. Emergent drug resistance with integrase strand transfer inhibitor-based regimens.
Lepik KJ; Harrigan PR; Yip B; Wang L; Robbins MA; Zhang WW; Toy J; Akagi L; Lima VD; Guillemi S; Montaner JSG; Barrios R
AIDS; 2017 Jun; 31(10):1425-1434. PubMed ID: 28375875
[TBL] [Abstract][Full Text] [Related]
25. INSTI-Based Initial Antiretroviral Therapy in Adults with HIV, the HIV Outpatient Study, 2007-2018.
Mayer S; Rayeed N; Novak RM; Li J; Palella FJ; Buchacz K;
AIDS Res Hum Retroviruses; 2021 Oct; 37(10):768-775. PubMed ID: 34030459
[TBL] [Abstract][Full Text] [Related]
26. Risk Factors for Weight Gain Following Switch to Integrase Inhibitor-Based Antiretroviral Therapy.
Lake JE; Wu K; Bares SH; Debroy P; Godfrey C; Koethe JR; McComsey GA; Palella FJ; Tassiopoulos K; Erlandson KM
Clin Infect Dis; 2020 Dec; 71(9):e471-e477. PubMed ID: 32099991
[TBL] [Abstract][Full Text] [Related]
27. Integrase strand-transfer inhibitor use and cardiovascular events in adults with HIV: an emulation of target trials in the HIV-CAUSAL Collaboration and the Antiretroviral Therapy Cohort Collaboration.
Rein SM; Lodi S; Logan RW; Touloumi G; Antoniadou A; Wittkop L; Bonnet F; van Sighem A; van der Valk M; Reiss P; Klein MB; Young J; Jarrin I; d'Arminio Monforte A; Tavelli A; Meyer L; Tran L; Gill MJ; Lang R; Surial B; Haas AD; Justice AC; Rentsch CT; Phillips A; Sabin CA; Miro JM; Trickey A; Ingle SM; Sterne JAC; Hernán MA;
Lancet HIV; 2023 Nov; 10(11):e723-e732. PubMed ID: 37923486
[TBL] [Abstract][Full Text] [Related]
28. Weight Gain Associated With Integrase Stand Transfer Inhibitor Use in Women.
Kerchberger AM; Sheth AN; Angert CD; Mehta CC; Summers NA; Ofotokun I; Gustafson D; Weiser SD; Sharma A; Adimora AA; French AL; Augenbraun M; Cocohoba J; Kassaye S; Bolivar H; Govindarajulu U; Konkle-Parker D; Golub ET; Lahiri CD
Clin Infect Dis; 2020 Jul; 71(3):593-600. PubMed ID: 31504324
[TBL] [Abstract][Full Text] [Related]
29. Risk of Immune Reconstitution Inflammatory Syndrome With Integrase Inhibitors Versus Other Classes of Antiretrovirals: A Systematic Review and Meta-analysis of Randomized Trials.
Zhao Y; Hohlfeld A; Namale P; Meintjes G; Maartens G; Engel ME
J Acquir Immune Defic Syndr; 2022 Jun; 90(2):232-239. PubMed ID: 35175970
[TBL] [Abstract][Full Text] [Related]
30. Integrase strand transfer inhibitor-based regimen is related with a limited HIV-1 V3 loop evolution in clinical practice.
Alteri C; Scutari R; Bertoli A; Armenia D; Gori C; Fabbri G; Mastroianni CM; Cerva C; Cristaudo A; Vicenti I; Bruzzone B; Zazzi M; Andreoni M; Antinori A; Svicher V; Ceccherini-Silberstein F; Perno CF; Santoro MM
Virus Genes; 2019 Jun; 55(3):290-297. PubMed ID: 30796743
[TBL] [Abstract][Full Text] [Related]
31. Natural polymorphism S119R of HIV-1 integrase enhances primary INSTI resistance.
Hachiya A; Ode H; Matsuda M; Kito Y; Shigemi U; Matsuoka K; Imamura J; Yokomaku Y; Iwatani Y; Sugiura W
Antiviral Res; 2015 Jul; 119():84-8. PubMed ID: 25956162
[TBL] [Abstract][Full Text] [Related]
32. Virological response to integrase strand transfer inhibitor-based antiretroviral combinations in HIV-1 group O-infected patients.
Alessandri-Gradt E; Unal G; Leoz M; Plantier JC;
AIDS; 2019 Jul; 33(8):1327-1333. PubMed ID: 30950879
[TBL] [Abstract][Full Text] [Related]
33. Comparison of HIV-Infected and Noninfected Patients Undergoing Bariatric Surgery: The ObeVIH Study.
Pourcher V; Capeau J; Dudoit Y; Boccara F; Soulié C; Ndoadoumgue AL; Charlotte F; Fellahi S; Bastard JP; Béréziat V; Lagathu C; Marcelin AG; Peytavin G; Boutron-Ruault MC; Tubbax C; D'Avout D'Auerstaedt A; Valantin MA; Schneider L; Costagliola D; Katlama C; Assoumou L; Pourcher G
J Acquir Immune Defic Syndr; 2022 Jun; 90(2):240-248. PubMed ID: 35185138
[TBL] [Abstract][Full Text] [Related]
34. Antiretroviral drug class and anaemia risk in the current treatment era among people living with HIV in the USA: a clinical cohort study.
Harding BN; Whitney BM; Nance RM; Crane HM; Burkholder G; Moore RD; Mathews WC; Eron JJ; Hunt PW; Volberding P; Rodriguez B; Mayer K; Saag MS; Kitahata MM; Heckbert SR; Delaney JAC
BMJ Open; 2020 Mar; 10(3):e031487. PubMed ID: 32198297
[TBL] [Abstract][Full Text] [Related]
35. Review of integrase strand transfer inhibitors for the treatment of human immunodeficiency virus infection.
Park TE; Mohamed A; Kalabalik J; Sharma R
Expert Rev Anti Infect Ther; 2015; 13(10):1195-212. PubMed ID: 26293294
[TBL] [Abstract][Full Text] [Related]
36. Brief Report: Weight Gain in Persons With HIV Switched From Efavirenz-Based to Integrase Strand Transfer Inhibitor-Based Regimens.
Norwood J; Turner M; Bofill C; Rebeiro P; Shepherd B; Bebawy S; Hulgan T; Raffanti S; Haas DW; Sterling TR; Koethe JR
J Acquir Immune Defic Syndr; 2017 Dec; 76(5):527-531. PubMed ID: 28825943
[TBL] [Abstract][Full Text] [Related]
37. Impact of transmitted HIV-1 drug resistance on the efficacy of first-line antiretroviral therapy with two nucleos(t)ide reverse transcriptase inhibitors plus an integrase inhibitor or a protease inhibitor.
Spertilli Raffaelli C; Rossetti B; Paglicci L; Colafigli M; Punzi G; Borghi V; Pecorari M; Santoro MM; Penco G; Antinori A; Zazzi M; De Luca A; Zanelli G
J Antimicrob Chemother; 2018 Sep; 73(9):2480-2484. PubMed ID: 29945251
[TBL] [Abstract][Full Text] [Related]
38. Integrase strand transfer inhibitor (INSTI)-resistance mutations for the surveillance of transmitted HIV-1 drug resistance.
Tzou PL; Rhee SY; Descamps D; Clutter DS; Hare B; Mor O; Grude M; Parkin N; Jordan MR; Bertagnolio S; Schapiro JM; Harrigan PR; Geretti AM; Marcelin AG; Shafer RW;
J Antimicrob Chemother; 2020 Jan; 75(1):170-182. PubMed ID: 31617907
[TBL] [Abstract][Full Text] [Related]
39. Changes in central adipose tissue after switching to integrase inhibitors.
Debroy P; Feng H; Miao H; Milic J; Ligabue G; Draisci S; Besutti G; Carli F; Menozzi M; Mussini C; Guaraldi G; Lake JE
HIV Res Clin Pract; 2020 Dec; 21(6):168-173. PubMed ID: 33459579
[No Abstract] [Full Text] [Related]
40. An assessment of weight change associated with the initiation of a protease or integrase strand transfer inhibitor in patients with human immunodeficiency virus.
Chow W; Donga P; Côté-Sergent A; Rossi C; Lefebvre P; Lafeuille MH; Emond B; Hardy H
Curr Med Res Opin; 2020 Aug; 36(8):1313-1323. PubMed ID: 32459155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]